Interaction of Statins and Nondepolarizing Muscle Relaxants
NCT ID: NCT02222519
Last Updated: 2014-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2014-10-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Characteristics Associated With Statin Therapy
NCT00990834
Impact of Statin Therapy on Muscle Mitochondrial Function and Aerobic Capacity
NCT03351998
Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia
NCT00590408
Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs
NCT00797407
Metabolic Features of Post-Myopathy Patients Associated With Statin Treatment
NCT01040650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Statin use group
patients taking statins for at least 3 months
Rocuronium
Rocuronium 0.6mg/kg iv single dose
non statin use
no history of taking statin
Rocuronium
Rocuronium 0.6mg/kg iv single dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rocuronium
Rocuronium 0.6mg/kg iv single dose
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients taking statins for at least 3 months and those who had never used statins were considered to be eligible
Exclusion Criteria
* Spinal surgery
* Surgery involving extensive muscle manipulation
* History of liver and kidney failure
* Neuromuscular disease
* Susceptibility to or family history of malignant hyperthermia
* Extensive denervation of skeletal muscle
* Chronic pain syndromes
* Taking medications that might interact with the effect of rocuronium or serum myoglobin difficult intubation
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huang-wei LV
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huang-wei LV
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Huangwei Lv, Professor
Role: STUDY_DIRECTOR
the Anesthesiology Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014071801
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.